Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diagnostic Imaging

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 85 articles: HTML format

Single Articles

March 2026
1. BIANCHINI E, Alsubai SE, Alqahtani F, Sgreva S, et al
   Characterization of Biomarker Profiles in Patients with Coronary Artery Disease: A Prospective Coronary Computed Tomography Angiography Study.
   Am Heart J. 2026 Mar 7:107423. doi: 10.1016/j.ahj.2026.107423.
   PubMed     Abstract available
   
   
   February 2026
2. HE WJ, Prescott BR, Xanthakis V, Mitchell GF, et al
   Association of obesity subphenotypes with indices of cardiac remodeling in the Framingham heart study.
   Am Heart J. 2026;292:107292.
   PubMed     Abstract available
   
   
   
3. GIROLAMO O, Ismail MD, Tavella R, Ooi EL, et al
   Functional coronary angiogram findings in angina with non-obstructive coronary arteries patients with coronary slow flow.
   Am Heart J. 2026;292:107287.
   PubMed     Abstract available
   
   
   
4. ROSSANO J, Canter C, Wolf C, Favatella N, et al
   Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial.
   Am Heart J. 2026;292:107283.
   PubMed     Abstract available
   
   
   
5. YOSHIDA Y, Zu Y, Aguilar D, Ferdinand KC, et al
   Cumulative effect of hyperglycemia and insulin resistance on cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
   Am Heart J. 2026;292:107276.
   PubMed     Abstract available
   
   
   
6. FUR CB, Olsen NT, Lassen JF, Eftekhari A, et al
   Design and rationale of aspirin versus aspirin and fondaparinux prior to early invasive strategy in patients with NSTEMI: The FOXY trial.
   Am Heart J. 2026;292:107274.
   PubMed     Abstract available
   
   
   January 2026
7. ARMSTRONG PW, Zheng Y, Welsh RC, Sinnaeve PR, et al
   Primary Percutaneous Coronary Intervention within the First Hour: Insights from Early-Treated Patients with ST-Elevation Myocardial Infarction.
   Am Heart J. 2026 Jan 29:107363. doi: 10.1016/j.ahj.2026.107363.
   PubMed     Abstract available
   
   
   
8. CHEN X, Li S, Wang B, Chen G, et al
   Staged interventional strategies for acute ST-segment elevation myocardial infarction patient with multi-vessel disease: Rationale and design of a multicenter, randomized STAGED trial.
   Am Heart J. 2026 Jan 13:107352. doi: 10.1016/j.ahj.2026.107352.
   PubMed     Abstract available
   
   
   
9. DILETTI R, Daemen J, Faurie B, Barbierato M, et al
   Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures: the IVUS CHIP Trial study design.
   Am Heart J. 2026 Jan 3:107339. doi: 10.1016/j.ahj.2026.107339.
   PubMed     Abstract available
   
   
   
10. TAMARAPPOO B, Wolny R, Tomasino GF, Berman D, et al
    Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis.
    Am Heart J. 2026 Jan 2:107340. doi: 10.1016/j.ahj.2026.107340.
    PubMed     Abstract available
    
    
    
11. HADA M, Collet C, Storozhenko T, Munhoz D, et al
    Rationale and design of European microcirculatory resistance and absolute flow team: The Euro-CRAFT registry.
    Am Heart J. 2026;291:136-143.
    PubMed     Abstract available
    
    
    
12. EGBE AC, Abozied O, Abdelhalim AT, Jain CC, et al
    Relationship between left atrial stiffness, pulmonary congestion, and impaired aerobic capacity in adults with repaired coarctation of aorta.
    Am Heart J. 2026;291:89-100.
    PubMed     Abstract available
    
    
    
13. TSIGKAS G, Trigka-Vasilakopoulou A, Apostolos A, Papafaklis M, et al
    Distal versus conventional transradial artery access for coronary catheterization in patients with STEMI (DR-STEMI): Rationale and design of an international, multicenter, randomized trial.
    Am Heart J. 2026;291:73-80.
    PubMed     Abstract available
    
    
    December 2025
14. ALEXANDRINO FB, Schlesinger R, Bird J, Lee E, et al
    Integrating AI-ECG and Point-of-Care Cardiac Ultrasound for Screening Structural Heart Disease: A Proof-of-Concept Study.
    Am Heart J. 2025 Dec 31:107337. doi: 10.1016/j.ahj.2025.107337.
    PubMed     Abstract available
    
    
    
15. SORGAARD MH, Kristensen AT, Eskesen K, Kofoed KF, et al
    Coronary Computed Tomography Angiography Versus Invasive Coronary Angiography for Interventional Triage in Acute Coronary Syndrome - Design of the Randomized TRACTION Trial.
    Am Heart J. 2025 Dec 6:107325. doi: 10.1016/j.ahj.2025.107325.
    PubMed     Abstract available
    
    
    
16. MCCARTHY CP, Ballantyne CM, Blankstein R, Budoff MJ, et al
    Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics.
    Am Heart J. 2025;290:325-338.
    PubMed     Abstract available
    
    
    
17. ALSAIED T, Li R, Grant H, Schiff MD, et al
    Defining diastolic dysfunction post-Fontan: Threshold, risk factors, and associations with outcomes.
    Am Heart J. 2025;290:288-296.
    PubMed     Abstract available
    
    
    
18. LI Y, Schiff M, Olivieri LJ, Christopher AB, et al
    The long-term effect of the Fontan fenestration on clinical outcomes: A FORCE registry study.
    Am Heart J. 2025;290:105-114.
    PubMed     Abstract available
    
    
    
19. GALLEGOS FN, Bernstein D, Punn R, Long J, et al
    Systolic performance of the single ventricle, exercise capacity, and endothelial function in pediatric Fontan patients.
    Am Heart J. 2025;290:58-68.
    PubMed     Abstract available
    
    
    November 2025
20. LI J, Wang ZY, Yan J, Li WH, et al
    Prospective, multicenter, randomized controlled study on the efficacy and safety of intravascular ultrasound-guided drug-coated balloon for de novo small-vessel coronary lesions: Design and rationale of the DCB-IVUS trial.
    Am Heart J. 2025 Nov 18:107307. doi: 10.1016/j.ahj.2025.107307.
    PubMed     Abstract available
    
    
    
21. GURVITZ M, Roseman A, Sahakian L, Calderon J, et al
    Design and rationale of "Antecedents and correlates of well-being in young adults with congenital heart disease in the Boston Circulatory Arrest Study (BCAS-adult)".
    Am Heart J. 2025;289:127-137.
    PubMed     Abstract available
    
    
    
22. RAVI SN, O'Shea M, Baqal O, Fatunde OA, et al
    The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy.
    Am Heart J. 2025;289:28-37.
    PubMed     Abstract available
    
    
    
23. BRUNS B, Elsous N, Burghaus I, Steyrer K, et al
    Rationale and design of the cyclosporine in Takotsubo syndrome (CIT) trial.
    Am Heart J. 2025;289:147-157.
    PubMed     Abstract available
    
    
    October 2025
24. IGLESIAS JF, Leibundgut G, Heg D, Gasparini GL, et al
    Distal versus conventional radial large-bore access for percutaneous coronary intervention of complex coronary lesions: Rationale and design of the DISCO COMPLEX randomized superiority trial.
    Am Heart J. 2025 Oct 18:107291. doi: 10.1016/j.ahj.2025.107291.
    PubMed     Abstract available
    
    
    September 2025
25. WONG J, Smith J, Soh CH, Howden E, et al
    Risk-Guided Disease Management To Prevent Heart Failure In Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial.
    Am Heart J. 2025 Sep 16:S0002-8703(25)00331-X. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
26. GIOIA GD, Ferrera A, Mestrini V, Monosilio S, et al
    Myocardial Work Indexes in elite athletes: An Emerging Echocardiographic Tool to confirm physiologic cardiac remodeling in elite athletes with mildly reduced systolic function.
    Am Heart J. 2025 Sep 8:S0002-8703(25)00324-2. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
27. FEISTRITZER HJ, Jobs A, Zeymer U, Schneider S, et al
    Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial.
    Am Heart J. 2025;287:94-106.
    PubMed     Abstract available
    
    
    August 2025
28. PARK HS, Suh CH, Ahn JM, Kang DY, et al
    Effect of Cerebral Embolic Protection Device on New Cerebral Embolism During Transcatheter Aortic Valve Replacement: A Prospective Sentinel Registry.
    Am Heart J. 2025 Aug 13:S0002-8703(25)00296-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
29. BOERHOUT CKM, Namba HF, Liu T, Beijk MAM, et al
    Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testing.
    Am Heart J. 2025;286:1-13.
    PubMed     Abstract available
    
    
    July 2025
30. VAKILPOUR A, Levin MG, Anyanwu EC, Denduluri S, et al
    Referral patterns and clinical outcomes in patients with severe aortic stenosis: A multicenter cohort study.
    Am Heart J. 2025 Jul 22:S0002-8703(25)00223-6. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
31. COSTA IBSDS, Furtado RHM, Drager LF, de Barros E Silva PGM, et al
    Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: Design and rationale of the CARDIOTOX trial.
    Am Heart J. 2025;285:1-11.
    PubMed     Abstract available
    
    
    June 2025
32. HOPPER I, Marwick TH, Wolfe R, Amerena J, et al
    STAREE-HEART: a randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants.
    Am Heart J. 2025 Jun 12:S0002-8703(25)00193-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
33. CUTLIP DE, Mehran R, Doros G, Kaplinskiy V, et al
    Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: Rationale and design.
    Am Heart J. 2025;284:11-19.
    PubMed     Abstract available
    
    
    May 2025
34. GENG Q, Ying Z, Zhenyan M, Renqiang Y, et al
    Long-term Prognostic Role of Persistent Microvascular Obstruction Determined by Cardiac Magnetic Resonance for ST-segment Elevation Myocardial Infarction.
    Am Heart J. 2025 May 29:S0002-8703(25)00187-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
35. KITTIPIBUL V, Cyr DD, Harrington J, Lala A, et al
    Structural Abnormalities and Effects of Sacubitril/Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure: The PARAGLIDE-HF Trial.
    Am Heart J. 2025 May 22:S0002-8703(25)00161-9. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
36. MAINI AS, Abu-Much A, Redfors B, Wollmuth JR, et al
    Outcomes Among Patients with Coronary Bifurcation Lesions Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention.
    Am Heart J. 2025 May 22:S0002-8703(25)00176-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
37. WHITE HD, O'Brien SM, Boden WE, Fremes SE, et al
    Use of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention and Associated Outcomes in the ISCHEMIA Trial.
    Am Heart J. 2025 May 20:S0002-8703(25)00165-6. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
38. RAI B, Yildiz M, Bergstedt S, Bandari A, et al
    Diversity of Electrocardiographic Patterns in Left Main Culprit Acute ST-Elevation Myocardial Infarction.
    Am Heart J. 2025 May 14:S0002-8703(25)00164-4. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
39. JAMES S, Christoffersen AD, David JP, Hacker M, et al
    Effect of Once-Weekly Subcutaneous Semaglutide on Arterial Inflammation in People with Type 2 Diabetes and Cardiovascular Disease Using PET-MRI: Primary Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Am Heart J. 2025 May 7:S0002-8703(25)00156-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
40. BALTER S, Moses J, Hyasat K, Collins M, et al
    Evolving operator practices reduced patient radiation dose in interventional cardiology: Trends in a single center.
    Am Heart J. 2025;283:5-16.
    PubMed     Abstract available
    
    
    April 2025
41. BOCKUS L, Kassar A, Chahine Y, Chamoun N, et al
    Atrial fibrillation is associated with higher oxygen extraction in the human heart.
    Am Heart J. 2025 Apr 15:S0002-8703(25)00129-2. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
42. SOMSEN YBO, de Winter RW, Wu J, Hoek R, et al
    Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial.
    Am Heart J. 2025 Apr 7:S0002-8703(25)00105-X. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
43. ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al
    Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension.
    Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
44. COSSETTE F, Trifan A, Prevost-Marcotte G, Doolub G, et al
    Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis.
    Am Heart J. 2025;282:93-102.
    PubMed     Abstract available
    
    
    March 2025
45. NOORY N, Westin O, Borgersen EH, Kragelund C, et al
    Absence of Coronary Artery Disease in Patients Undergoing Coronary Imaging and Association with Amyloidosis - A Danish Nationwide Study.
    Am Heart J. 2025 Mar 26:S0002-8703(25)00093-6. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
46. ONUMA Y, Ninomiya K, Sjauw K, Damman P, et al
    Accuracy of Instantaneous Wave-free Ratio and Fractional Flow Reserve Derived From Single Coronary Angiographic Projections.
    Am Heart J. 2025 Mar 11:S0002-8703(25)00071-7. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
47. DONAZZAN L, Bulian F, Maines M, Erckert M, et al
    Effect of rate-adaptive atrial support compared to VDD pacing in cardiac resynchronization therapy recipients: A randomized cross-over study.
    Am Heart J. 2025;281:149-156.
    PubMed     Abstract available
    
    
    
48. TRUONG DT, Harty BJ, Bainton J, Baker A, et al
    Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study.
    Am Heart J. 2025;281:32-42.
    PubMed     Abstract available
    
    
    February 2025
49. TAKAHASHI T, Wei J, Iribarren AC, Gulati M, et al
    Rationale and design of the Women's Ischemia Syndrome Evaluation Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure With Preserved Ejection Fraction (WISE Pre-HFpEF).
    Am Heart J. 2025 Feb 24:S0002-8703(25)00056-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
50. CHATUR S, Seth M, Casey M, Thompson M, et al
    Reminders EMbedded IN PCI Reports to Optimize Discharge Diabetes Mellitus Care (REMIND-DM): Rationale, Design, and Baseline Characteristics.
    Am Heart J. 2025 Feb 21:S0002-8703(25)00019-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
51. ERRIQUEZ A, Colaiori I, Hakeem A, Guiducci V, et al
    Functional Coronary Angiography to Indicate and Guide Revascularization in STEMI Patients with Multivessel Disease: Rationale and Design of the AIR-STEMI trial: Functional coronary angiography in STEMI patients.
    Am Heart J. 2025 Feb 19:S0002-8703(25)00042-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
52. PASQUALIN G, Misra A, Gauvreau K, Sanders SP, et al
    Ventricular-Arterial Coupling is associated with Clinical Outcomes in Patients with Systemic Right Ventricle.
    Am Heart J. 2025 Feb 19:S0002-8703(25)00043-2. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
53. BAINEY KR, Welsh RC, Zheng Y, Arias-Mendoza A, et al
    Pharmaco-invasive Strategy and Dosing of Tenecteplase in STEMI Patients 60 to <75 Years: An Inter-trial Comparison of the STREAM-1 and STREAM-2 Trials: Comparison of Patients 60 to <75 Years in STREAM-1 and -2.
    Am Heart J. 2025 Feb 12:S0002-8703(25)00032-8. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
54. GAO XF, Kan J, Wu HY, Chen J, et al
    Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention in Patients with Diabetes Mellitus: Rationale and design of an International, Multicenter, Randomized IVI-DIABETES Trial.
    Am Heart J. 2025 Feb 4:S0002-8703(25)00017-1. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
55. WANG G, Zhang R, Chen SL, Wang J, et al
    Targeted Therapy with a Localized abluminal Groove Low-Dose Sirolimus-Eluting Bioabsorbable Polymer Coronary Stent in Chronic Total Occlusions: The TARGET CTO Non-Inferiority Randomized Trial.
    Am Heart J. 2025 Feb 3:S0002-8703(25)00018-3. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    January 2025
56. STEG PG, Nicolas J, Baber U, Sartori S, et al
    Characterizing High-Risk Enrollment Criteria and Impact on Clinical Outcomes in a Large Randomized Clinical Trial: Insights From the TWILIGHT Trial.
    Am Heart J. 2025 Jan 29:S0002-8703(25)00016-X. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
57. POLOMSKI EAS, Heemelaar JC, de Ronde MES, Al Jaff AAM, et al
    Increased Prevalence of Coronary Atherosclerosis in Cancer Survivors: A Retrospective Matched Cross-sectional Study with Coronary CT Angiography.
    Am Heart J. 2025 Jan 8:S0002-8703(25)00004-3. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
58. SHECHTER A, Gupta A, Kaewkes D, Taheri H, et al
    Implications of an Off-Hours Setting in Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation.
    Am Heart J. 2025 Jan 2:S0002-8703(24)00341-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    December 2024
59. TRISTAO-PEREIRA C, Fuster V, Lopez-Jimenez A, Fernandez-Pena A, et al
    Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain study.
    Am Heart J. 2024;278:195-207.
    PubMed     Abstract available
    
    
    November 2024
60. ABRAMOWITZ SD, Marko X, D'Souza D, Noor S, et al
    Rationale and Design of the DEFIANCE Study: A Randomized Controlled Trial of Mechanical Thrombectomy Versus Anticoagulation Alone for Iliofemoral Deep Vein Thrombosis.
    Am Heart J. 2024 Nov 2:S0002-8703(24)00278-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    October 2024
61. BARONE-ROCHETTE G, Vanzetto G, Danchin N, Steg PG, et al
    Rationale and design of the multicentric randomized EVAOLD trial: evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia.
    Am Heart J. 2024 Oct 22:S0002-8703(24)00274-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
62. THURAIAIYAH J, Jorgensen TH, Jensen JM, Fuchs A, et al
    Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT.
    Am Heart J. 2024 Oct 5:S0002-8703(24)00264-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    September 2024
63. NELSON MD, Gomez-Arnold JM, Wei J, Lauzon M, et al
    Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) Study.
    Am Heart J. 2024 Sep 2:S0002-8703(24)00224-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
64. LINDLEY KJ, Barker C, Mahmoud Z, Raghuraman N, et al
    Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction.
    Am Heart J. 2024;275:192-199.
    PubMed     Abstract available
    
    
    
65. RWEBEMBERA J, Ndagire E, Carvalho N, Webel AR, et al
    Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Am Heart J. 2024;275:74-85.
    PubMed     Abstract available
    
    
    August 2024
66. SOH CH, Wright L, Baumann A, Seidel B, et al
    Use of artificial intelligence-guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE-echo trial.
    Am Heart J. 2024;277:11-19.
    PubMed     Abstract available
    
    
    
67. STAHLI BE, Linke A, Westermann D, Van Mieghem NM, et al
    A Randomized Comparison of the Treatment Sequence of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Implantation: Rationale and Design of the TAVI PCI Trial.
    Am Heart J. 2024 Aug 7:S0002-8703(24)00184-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
68. DUARTE VE, Yamamura K, Economy KE, Graf JA, et al
    The effects of pregnancy in subjects with repaired tetralogy of Fallot.
    Am Heart J. 2024;274:95-101.
    PubMed     Abstract available
    
    
    July 2024
69. BURGOS LM, Vila RCB, Ballari FN, Goyeneche A, et al
    Inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure: a randomized pilot study (CAVAL US-AHF study).
    Am Heart J. 2024 Jul 31:S0002-8703(24)00181-9. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
70. ERBAY A, Penzel L, Abdelwahed YS, Heuberger A, et al
    Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease.
    Am Heart J. 2024 Jul 19:S0002-8703(24)00177-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
71. POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al
    Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    June 2024
72. ABOU-KARAM R, Tanguturi V, Cheng F, Elmariah S, et al
    Trial Designs A44002PZS Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: Rationale, design, and methods of the randomized controlled DETECT AS Trial.
    Am Heart J. 2024 Jun 29:S0002-8703(24)00163-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
73. JEYAPRAKASH P, Pathan F, Ozawa K, Robledo KP, et al
    Restoring microvascular circulation with diagnostic ultrasound and contrast agent: Rationale and Design of the REDUCE trial.
    Am Heart J. 2024 Jun 27:S0002-8703(24)00162-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
74. BRUNO F, Rampone JM, Islas F, Gorla R, et al
    Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after TAVR: insights from the Recovery TAVR registry.
    Am Heart J. 2024 Jun 3:S0002-8703(24)00137-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
75. SONG L, Guan C, Yu M, Sun Z, et al
    Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: rationale and design of the IRONMAN-II trial.
    Am Heart J. 2024 Jun 3:S0002-8703(24)00140-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    May 2024
76. KIM Y, Park H, Yoon HJ, Suh J, et al
    Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Study Protocol for a Randomized Controlled Non-Inferiority Trial.
    Am Heart J. 2024 May 7:S0002-8703(24)00119-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    April 2024
77. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
78. ETIWY M, Flannery LD, Li SX, Morrison FJ, et al
    Examining Lack of Referrals to Heart Valve Specialists as Mechanisms of Potential Underutilization of Aortic Valve Replacement.
    Am Heart J. 2024 Apr 13:S0002-8703(24)00093-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    March 2024
79. MILLER HE, Tierney S, Stefanick ML, Mayo JA, et al
    Vascular health years after a hypertensive disorder of pregnancy: The EPOCH Study.
    Am Heart J. 2024 Mar 12:S0002-8703(24)00055-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    February 2024
80. MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al
    Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies.
    Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
81. DEHGHANI P, Singh J, Mancini GBJ, Stanberry L, et al
    Angiographic characteristics of Patients with STEMI and COVID-19 - Insights from NACMI Registry.
    Am Heart J. 2024 Feb 21:S0002-8703(24)00039-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    January 2024
82. CEVIK E, Tas A, Demirtakan ZG, Damman P, et al
    Intracoronary Electrocardiogram Detects Coronary Microvascular Dysfunction and Ischemia in Patients with No Obstructive Coronary Arteries Disease.
    Am Heart J. 2024 Jan 24:S0002-8703(24)00010-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    November 2023
83. MUNHOZ D, Collet C, Mizukami T, Yong A, et al
    Rationale and design of the pullback pressure gradient (PPG) global registry.
    Am Heart J. 2023;265:170-179.
    PubMed     Abstract available
    
    
    
84. BERMAN AN, Ginder C, Wang XS, Borden L, et al
    A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH).
    Am Heart J. 2023;265:40-49.
    PubMed     Abstract available
    
    
    September 2023
85. WENG Z, Zhao C, Qin Y, Liu C, et al
    Peripheral atherosclerosis in acute coronary syndrome patients with plaque rupture vs plaque erosion: A prospective coronary optical coherence tomography and peripheral ultrasound study.
    Am Heart J. 2023;263:159-168.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum